Banner Banner Banner Banner
Canine Epilepsy Banner Logo
Canine Epilepsy Home Owners Information Veterinary Resource Monitoring Programme Research Links
Banner
  Drugs Image  
  Clinical Information  
  Clinical Information  
  Pathophysiology  
  Seizure Investigation  
  Clinical Pathology  
  Imaging  
  Standard Management  
  Refractory Epilepsy  
  Status epilepticus  
  Monitoring Therapy  
  Phenobarbitone  
  Bromide  
  Diazepam  
  Zonisamide  
  Additional drugs  
  Other management  
  Useful References  
  Client Support  
  Neurology Specialists  
  Case History  
  Seizures Quiz  
  Base Of Menu  

 

Formulary: Bromide

Bromide is an old anticonvulsant drug. It works by replacing negatively charged chloride ions through the chloride channels causing neuronal hyperpolarisation. Bromide has synergistic effect with drugs that enhance chloride conduction (such as phenobarbitone). Bromide is usually administered as the potassium salt (KBr) but sodium salts may be used in patients with adrenal insufficiency and renal dysfunction.

Bromide is slowly excreted by the kidneys without the requirement for hepatic biotransformation. Bromide has a very long half-life (25 to 46 days) in dogs so steady state serum concentration is not reached for 3 to 6 months.

Download Fact Sheet Bromide ver.100308

Indications
Bromide is commonly used in combination with phenobarbitone in refractory epileptics or in patients that have suffered liver disease. It should be used with caution in patients with impaired renal function.


Dose
Recommended oral dosage in dogs is 30 mg/kg once daily. Therapeutic serum concentrations are 880 to 3000 mg/ml as a solitary agent and 810 to 2400 mg/ml in combination with phenobarbitone.

If adequate serum concentrations are needed rapidly, a loading dose of bromide can be used. For a more rapid effect than that obtained with oral maintenance dosing regimes, a per rectum loading protocol has been devised. Intrarectal administration may be preferred in the patient that is heavily sedated from prior diazepam and phenobarbitone administration. A loading dose for KBr (600 mg/kg) can be administered over a 24-hour period as 6 per rectum boluses (100mg/kg, q 4h). The side-effects seen with the use of this regime may be transient diarrhoea and sedation.


Side effects
Tend to be dose-dependent and include: polyuria, polydipsia, polyphagia, transient sedation or ataxia during the first 2 to 3 weeks (before tolerance develops). Hyperactivity and pruritus may be seen occasionally. Overdosage may be associated with ataxia, depression, tremors, neuropathies, stupor or coma (bromism) – sodium chloride IV or orally accompanied by furosemide may be considered.

Bromide is a gastric irritant and may cause vomiting – this may be minimised by administering bromide with or shortly after feeding.


References

Nichols ES, Trepanier LA, Linn K (1996) Bromide toxicosis secondary to renal
insufficiency in an epileptic dog.
JAVMA 208, 231-233. - PubMed -

Podell M, Fenner WR (1993) Bromide therapy in refractory canine idiopathic epilepsy. JVIM 7, 318-327. - PubMed -

Shaw N, Trepanier LA, Center SA et al (1996) High dietary chloride content associated with loss of therapeutic serum bromide concentrations in an epileptic dog. JAVMA 208, 234-236. - PubMed -

Yohn SE, Wallace BM, Sharp PE (1992) Bromide toxicosis (bromism) in a dog treated with potassium bromide for refractory seizures. JAVMA 201, 468-470. - PubMed -

 

Previous PageBack to TopNext Page

BaseImage BaseImage BaseImage BaseImage Base Image2 Logos BaseImage BaseImage